Insight of Tp53 Mutations and their effect on Protein in Different Feline and Canine Neoplasms

Rashid Saif, Ezza Khan, Arooj Azhar, Shahnaz Choudhary, Tanveer Hussain, Masroor Ellahi Babar, Ali Raza Awan, Muhammad Tayyab, Saeeda Zia, Muhammad Wasim


Background: Mutations in the Tp53 gene, a tumor suppressor gene, may cause dysfunction in growing cells and hinder the phenomenon of apoptosis, an alleged cause of tumorigenesis. It is involved in conservation of the genome and DNA repair, mutations of this gene may cause the damaged cells to grow continuously.

Methods: The type of molecular changes in Tp53 gene and their effects on physiochemical and structural properties of this protein in various Canine and Feline cancers were observed in this study by using online bioinformatics tools.

Results: Our results indicated that lymphomas and perianal adenocarcinomas (PAC) have the same mutation at c. 104, while mammary tumors and canine transmissible venereal tumor (CTVT) contain different mutations. Referring to changes in protein, synonymous mutations in granulomas were observed while certain mutations in squamous cell carcinoma (SCC) and head & neck tumors were detected in Canis familiaris. In Felis catus, the mutant protein was similar to wild type protein with exception of mutant 5 of mammary tumor, which had a deletion at the 287 amino acid position.

Conclusion: The insight gathered on the p53 mutant proteins in both species aided our understanding of the in-vivo fate of the p53 protein and its isoforms and the effects that morphological changes can have on the fate of cells. Furthermore, isolation of this protein may augment our understanding about the structural biology of these proteins.

Full Text:



Fromentel CCD, Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes, Chromosomes and Cancer, (1992); 4(1): 1-15.

Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature, (1989); 342(6250): 705-708.

Liu J, Zhang C, Feng Z. Tumor suppressor p53 and its gain-of-function mutants in cancer. Acta Biochimica et Biophysica Sinica, (2014); 46(3): 170-179.

Bellini MF, Cadamuro ACT, Succi M, Proença MA, Silva AE. Alterations of the TP53 gene in gastric and esophageal carcinogenesis. BioMed Research International, (2012); 2012.

Moro J, Tinucci-Costa M, Silveira A, Gerardi D, Alessi Reactivity of p53 protein in canine transmissible venereal tumor. Arquivo Brasileiro de Medicina Veterinária e Zootecnia, (2010); 62(2): 318-323.

Gentschev I, Patil SS, Petrov I, Cappello J, Adelfinger M, et al. Oncolytic virotherapy of canine and feline cancer. Viruses, (2014); 6(5): 2122-2137.

Pang L, Blacking T, Else R, Sherman A, Sang H, et al. Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM/p53 DNA damage pathway. The Veterinary Journal, (2013); 196(3): 414-423.

Veldhoen N, Stewart J, Brown R, Milner J. Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog. Oncogene, (1998); 16(2).

Stockmann D, Ferrari H, Andrade A, Cardoso T, Luvizotto M. Detection of the tumour suppressor gene TP53 and expression of p53, Bcl‐2 and p63 proteins in canine transmissible venereal tumour. Veterinary and Comparative Oncology, (2011); 9(4): 251-259.

Cho K-W, Okuda M, Endo Y, Satoh H, Kang C-B, et al. Assignment of the cat p53 tumor suppressor gene (TP53) to cat chromosome E1p14→ p13 by fluorescence in situ hybridization. Cytogenetic and Genome Research, (1997); 79(1-2): 145-146.

Buchan DW, Ward S, Lobley AE, Nugent T, Bryson K, et al. Protein annotation and modelling servers at University College London. Nucleic Acids Research, (2010); gkq427.

Beevers L (1982) Post-translational modifications. Nucleic Acids and Proteins in Plants I. Berlin, Germany: Springer. pp. 136-168.

Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, et al. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Research, (2003); 31(13): 3784-3788.

Ashokan K, Pillai M. In silico characterization of silk fibroin protein using computational tools and servers. Asian Journal of Experimental Science, (2008); 22265-274.

McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server. Bioinformatics, (2000); 16(4): 404-405.

Idicula‐Thomas S, Balaji PV. Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli. Protein Science, (2005); 14(3): 582-592.

Yang J-Y, Peng Z-L, Chen X. Prediction of protein structural classes for low-homology sequences based on predicted secondary structure. BMC Bioinformatics, (2010); 11(1): 1.

Buchan DW, Minneci F, Nugent TC, Bryson K, Jones DT. Scalable web services for the PSIPRED Protein Analysis Workbench. Nucleic Acids Research, (2013); 41(W1): W349-W357.

Marchler-Bauer A, Zheng C, Chitsaz F, Derbyshire MK, Geer LY, et al. CDD: conserved domains and protein three-dimensional structure. Nucleic Acids Research, (2012); gks1243.

Querol‐Audí J, Casañas A, Usón I, Luque D, Castón JR, et al. The mechanism of vault opening from the high resolution structure of the N‐terminal repeats of MVP. The EMBO journal, (2009); 28(21): 3450-3457.

Appella E, Anderson CW. Post‐translational modifications and activation of p53 by genotoxic stresses. European Journal of Biochemistry, (2001); 268(10): 2764-2772.


  • There are currently no refbacks.